SCHEMBL3880672

SCHEMBL3880672

CSc1ccc(F)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 6/20 0.46
SLC6A4 P31645 6/20 0.46
ALDH1A1 P00352 4/20 0.44
SLC6A3 Q01959 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
PDE7A Q13946 1/20 0.38
KEAP1 Q14145 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30908393 1.00 SLC6A2 (0.46) SLC6A2SLC6A4ALDH1A1SLC6A3NPC1
SCHEMBL1512264 0.82 ALDH1A1 (0.50) SLC6A2SLC6A4ALDH1A1SLC6A3NPC1
SCHEMBL31541178 0.81 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1SLC6A3NPC1
SCHEMBL4808061 0.81 ALDH1A1 (0.48) SLC6A2SLC6A4ALDH1A1SLC6A3NPC1
SCHEMBL16528615 0.77 SLC6A2 (0.50) SLC6A2SLC6A4ALDH1A1SLC6A3L3MBTL1
SCHEMBL8920417 0.76 CASP1 (0.48) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL29722916 0.76 ALDH1A1 (0.42) ALDH1A1KEAP1ADRA2AADRA2BADRA2C
SCHEMBL319042 0.76 ALDH1A1 (0.42) ALDH1A1KEAP1ADRA2AADRA2BADRA2C
SCHEMBL19985011 0.76 SLC6A2 (0.49) SLC6A2SLC6A4ALDH1A1SLC6A3L3MBTL1
SCHEMBL7596593 0.74 NPC1 (0.67) SLC6A2SLC6A4ALDH1A1SLC6A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3296294-A1 COMPOUND FOR TREATING OR PREVENTING BREAST CANCER Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd (CN) 2018-03-21 EP disclosed
WO-2009115393-A1 PROCESS FOR THE PREPARATION OF N-(1-PHENYLETHYL)ANILINES, SALTS, AND SOLVATES THEREOF USEFUL AS SEROTONIN 5-HT6 ANTAGONISTS LABORATORIOS DEL DR. ESTEVE, S. A. (ES) 2009-09-24 WO disclosed
EP-2103596-A1 Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-09-23 EP disclosed
EP-2103596-A1 Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-09-23 EP disclosed
US-7384966-B2 2-arylbenzothiazole derivatives PHARMINXO LIMITED (GB) 2008-06-10 US disclosed
US-6884801-B1 Imidazoline derivatives as alpha-1A adrenoceptor ligands SMITHKLINE BEECHAM CORPORATION (US) 2005-04-26 US disclosed
EP-1175406-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2002-01-30 EP disclosed
WO-2000066563-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2000-11-09 WO disclosed